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PLINICAL RESEARCH Interventional Cardiology
low-Flow Phenomenon During Carotid
rtery Intervention With Embolic Protection Devices
redictors and Clinical Outcome
van P. Casserly, MB, BCH,* Alex Abou-Chebl, MD,† Robert B. Fathi, MD, PHD,† David S. Lee, MD,†
acqueline Saw, MD,‡ Jose E. Exaire, MD,§ Samir R. Kapadia, MD,† Christopher T. Bajzer, MD,†
ay S. Yadav, MD†
enver, Colorado; Cleveland, Ohio; Vancouver, Canada; and Mexico City, Mexico
OBJECTIVES The purpose of this research was to define the predictors of the “slow-reflow” phenomenon
during carotid artery intervention with filter-type embolic protection devices (EPDs) and to
determine its prognostic significance.
BACKGROUND During carotid artery intervention using filter-type EPDs, we have observed cases in which
there is angiographic evidence of a significant reduction in antegrade flow in the internal
carotid artery proximal to the filter device, termed “slow-flow.” The predictors of this
phenomenon and its prognostic significance are unknown.
METHODS Using a single-center prospective carotid intervention registry, patients with slow-flow were
compared to patients with normal flow during carotid intervention with respect to clinical,
procedural, and lesion characteristics, and the 30-day incidence of death and stroke.
RESULTS A total of 414 patients underwent 453 carotid artery interventions using EPDs. Slow-flow
occurred in 42 patients (10.1%) undergoing 42 carotid interventions (9.3%), and most
commonly occurred after post-stent balloon dilatation (71.4%). Multivariate logistic regres-
sion analysis identified the following predictors of slow-flow: recent history (6 months) of
stroke or transient ischemic attack (odds ratio [OR] 2.8, 95% confidence interval [CI] 1.4 to
5.6, p  0.004), increased stent diameter (OR 1.4, 95% CI 1.02 to 1.94, p  0.044), and
increased patient age (OR 1.05, 95% CI 1.01 to 1.09, p  0.025). Among patients with
slow-flow, the 30-day incidence of stroke or death was 9.5% compared to 2.9% in patients
with normal flow (chi-square  4.73, p  0.03). This difference was driven by the disparity
in the 30-day incidence of stroke (9.5% vs. 1.7%).
CONCLUSIONS Slow-flow during carotid intervention with EPDs is a frequent event that is associated with
an excess risk of periprocedural stroke. The association of the phenomenon with clinically
symptomatic carotid lesions and use of larger stent diameters suggests that embolization of
vulnerable plaque elements may play a pathogenic role. (J Am Coll Cardiol 2005;46:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.05.0821466–72) © 2005 by the American College of Cardiology Foundation
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curing carotid artery intervention using filter-type embolic
rotection devices (EPDs), we have observed cases in which
here is angiographic evidence of a significant reduction in
ntegrade flow in the internal carotid artery (ICA) proximal
o the filter device (Fig. 1), termed “slow-flow” (1,2). The
ngiographic appearance is reminiscent of the no-reflow
henomenon initially described during percutaneous coro-
ary intervention in the absence of EPDs (3), although
hese two processes are clearly pathologically distinct. At
his time, the mechanism of slow-flow during carotid
ntervention is unknown. Our working hypothesis is that
articulate debris containing plaque elements results in
lockage of the filter pores, impeding antegrade flow. The
eduction in antegrade flow leads to a stagnant debris-
ontaining column of blood in the artery proximal to the
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ealth Sciences Center, Denver, Colorado; †Department of Cardiovascular Medi-
ine, Cleveland Clinic Foundation, Cleveland, Ohio; ‡Vancouver General Hospital,
ancouver, Canada; and §National Institute of Health, Mexico City, Mexico.a
Manuscript received January 26, 2005; revised manuscript received May 18, 2005,
ccepted May 31, 2005.lter. As a result, our practice has been to aspirate the
olumn of blood proximal to the filter in cases in which
ignificant slow-flow is observed, in an effort to minimize
he risk of distal embolization after filter collapse and
etrieval (Fig. 2).
In a large single-center experience, we prospectively
dentified all patients with slow-flow during carotid inter-
ention with filter-type EPDs. In an attempt to gain
nsights into the mechanism and prognostic significance of
he phenomenon, we sought to identify clinical, procedural,
r angiographic predictors of slow-flow, and to compare the
0-day clinical outcomes of patients with slow-flow versus
hose with normal flow during the procedure.
ETHODS
ll patients undergoing percutaneous carotid interventions
t the Cleveland Clinic Foundation are entered in a pro-
pective carotid intervention database, in which baseline
linical characteristics, procedural and angiographic data,
nd clinical outcomes are collected. From this database, we
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October 18, 2005:1466–72 Slow-Flow During Carotid Artery Interventiondentified all patients undergoing carotid intervention using
lter-type EPDs from the date of their initial use (February
000) until March 2004. Procedures in which slow-flow
ccurred were prospectively recorded.
Regarding angiographic data, the degree of carotid
tenosis was visually estimated. The length of carotid
esions was visually estimated using the diameter of the
uide catheter or sheath, or the length of interventional
quipment (i.e., angioplasty balloon or stent) as a refer-
nce dimension. The following carotid plaque morpho-
ogical characteristics were assessed qualitatively: the
resence of an ulcerated plaque surface, eccentric distri-
ution of plaque in vessel lumen, and prominent calcifi-
ation of the plaque.
The primary clinical outcome measure of this analysis was
rospectively defined as the incidence of stroke and/or death
t 30 days. Stroke was defined as a new neurologic deficit
hat persisted beyond 24 h.
arotid stent technique. All patients were treated with
re-procedural aspirin and clopidogrel (for at least 48 h) and
ere continued for a minimum of four weeks after the
ntervention. Intravenous heparin was administered intra-
rocedurally to achieve a target activated clotting time
ACT) of 300 s. After delivery of an 8-F guide catheter or
-F sheath in the common carotid artery, the lesion was
igure 1. Characteristic angiographic appearance of slow-flow (A and B) a
ith emboli protection devices (EPD). (A) Complete column of contrast in
Abbreviations and Acronyms
ACT activated clotting time
EPD embolic protection device
ICA  internal carotid artery
TIA  transient ischemic attackrtery (ECA). (B) Marked reduction in antegrade flow in the ICA with incom
here is no antegrade flow beyond the origin of the ICA (arrow). CCA  comrossed with a filter-type EPD. Most lesions were pre-
ilated with a coronary-type 4-mm diameter balloon, fol-
owed by deployment of a self-expanding nitinol stent, and
ost-dilation of the stent with a 5.0- to 5.5-mm diameter
alloon. Carotid flow was angiographically assessed after
ach step. When slow-flow was observed, multiple aspira-
ions of the column of blood proximal to the filter (for a
otal of 40 to 60 cc) were performed. This was achieved
sing a multipurpose catheter or the Export aspiration
atheter (Medtronic Inc., Minneapolis, Minnesota). At the
ompletion of the carotid intervention, the filter device was
etrieved, and final assessment of carotid and cerebral flow
as performed. Patients were discharged one day after an
ncomplicated procedure after evaluation by a neurologist.
utpatient follow-up with neurological assessment by a
eurologist was scheduled at 30 days.
tatistics. Continuous variables appear as mean values with
Ds and categorical variables as frequencies with percent-
ges. Using chi-square and Fisher exact (when any one cell
f a comparison table had less than five items in it) tests for
iscrete variables, and independent-samples t test for con-
inuous variables, the baseline clinical characteristics, and
rocedural and angiographic variables were compared be-
ween patients who experienced slow-flow during the pro-
edure with those who had normal flow. Binary logistic and
ultivariate logistic regression analyses were performed to
dentify univariate and multivariate predictors of slow-flow,
espectively. For this analysis, only the index procedure was
ncluded for patients with multiple procedures, and only
ata for the ICA lesion was included for patients with
ultiple lesions treated during the procedure. The fre-
uency of death and/or stroke at 30 days was calculated for
-flow (C) in the internal carotid artery (ICA) during carotid intervention
with mild reduction in antegrade flow compared with the external carotidnd no
ICAplete filling of the lumen, but contrast does flow beyond the EPD. In C,
mon carotid artery.
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Slow-Flow During Carotid Artery Intervention October 18, 2005:1466–72he slow-flow and normal flow groups. Kaplan-Meier
vent-free curves at 30 days were constructed, and chi-
quare test performed to assess for significance. Statistical
nalysis was performed using SPSS 9.0 statistical software
SPSS Inc., Chicago, Illinois) and JMP 5.1 statistical
oftware (SAS Institute, Cary, North Carolina).
igure 2. Schematic of proposed mechanism of slow-flow and rationale fo
laced in the distal internal carotid artery (ICA). (B and C) Balloon angio
laque causing occlusion of filter pores and accumulation of debris in stag
he filter removes the debris from the stagnant column of blood without aff
able 1. Clinical Demographics of Patient Populations
Clinical Demographics
Slow-Flow
(n  42)
Normal Flow
(n  372) p Value
en 32 (76) 260 (70)
ge (yrs) 73.8  9.1 70.6  9.4 0.035
MI 27.4  4.5 28.1  5.7
ymptomatic carotid lesion* 20 (48) 86 (23) 0.001
estenotic lesion
Stenosis post-CEA 8 (19) 90 (24)
In-stent restenosis 0 (0) 2 (0.5)
ontralateral occlusion 8 (19) 62 (17)
rior neck radiation 3 (7) 27 (7)
rior radical neck surgery 2 (5) 17 (5)
istory of prior stroke 12 (29) 84 (23)
istory of prior TIA 10 (24) 91 (25)
istory of myocardial infarction 21 (50) 146 (40)
istory of coronary artery
disease
34 (81) 290 (78)
reatinine clearance 69.2  32 71.2  32
OPD 7 (17) 69 (19)
moker
Prior 21 (50) 208 (56)
Current 9 (21) 61 (16)
iabetes mellitus 15 (36) 153 (41)
ypertension 39 (93) 332 (89)
yperlipidemia 32 (76) 300 (82)
ontinuous variables shown as means with SD in parentheses. Categorical variables
hown as frequencies with percentages in parentheses. *Transient ischemic attack
TIA) or stroke in distribution of ipsilateral anterior cerebral circulation in absence of
ther identifiable cause.(
BMI  body mass index; CEA  carotid endarterectomy; COPD  chronic
bstructive pulmonary disease.ESULTS
total of 414 patients underwent 453 carotid artery
nterventions using filter-type EPDs during the study pe-
iod. Slow-flow in the ICA occurred in 42 patients (10.1%)
uring 42 procedures (9.3%). Among patients with slow-
ow, complete absence of antegrade flow was observed in 10
atients (23.8%), while reduced antegrade flow was ob-
erved in the remaining 32 patients to varying degrees
76.2%). Slow-flow was detected at the following stages of
he procedure: after pre-dilation in one patient (2.4%), after
tent deployment in 11 patients (26.2%), and after post-
tent balloon dilatation in the remaining 30 patients
71.4%). Slow-flow resolved in all patients after retrieval of
he filter.
rediction of slow-flow. The clinical characteristics of the
2 patients with slow-flow and the remaining 372 patients
ith normal flow are shown in Table 1. Patients with
low-flow were older and more likely to have a history of an
nterior circulation transient ischemic attack (TIA) or
troke within the previous six months.
Table 2 lists the procedural variables for the slow-flow
nd normal flow groups. All of the 42 patients with
low-flow underwent a single carotid intervention during
he study period. These events were distributed evenly
hroughout the study period. The remaining 372 patients
nderwent a total of 411 carotid interventions during the
ame period. The mean peak procedural ACT and mean
eparin dose/kg were equivalent in both groups, as was the
ean fluoroscopic time for the procedure. Primary stenting
as performed in 10% of procedures, whereas balloon
ngioplasty or cutting balloon angioplasty alone was per-
ormed in 2% of patients in the normal flow group only. The
ost common stent type used was the Precise/Smart stent
iration prior to retrieval of filter. (A) Carotid bifurcation lesion with filter
and stenting results in distal embolization of debris from atherosclerotic
olumn of blood proximal to the filter. (D and E) Aspiration proximal to
the debris causing occlusion of the filter. CCA  common carotid artery.r asp
plasty
nant cCordis, Johnson & Johnson, Warren, New Jersey). During
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October 18, 2005:1466–72 Slow-Flow During Carotid Artery Interventionhe study period, four different filter-type EPDs were
tilized: Angioguard (Cordis, Miami, Florida), FilterWire
X/FilterWire EZ (Boston Scientific, Natick, Massachu-
etts), AccuNet (Guidant Corp., Indianapolis, Indiana), and
euroShield (Abbott, Galway, Ireland). The Angioguard
as the dominant filter employed, being used in 64% of all
rocedures.
A comparison of the lesion characteristics in the slow-
able 2. Procedural Variables
Procedural Variable
Slow-Flow
(n  42)
Normal Flow
(n  411)
eak procedural ACT (s) 304  55 297  38
eparin dose (U/kg) 70.4  28 69.5  22
luoroscopic time (min) 36.6  14 33.7  16
rocedure type
Primary stent 4 (10) 46 (11)
PTA/CB alone 0 (0) 8 (2)
PTA/stent 38 (91) 357 (87)
umber of stents per procedure
0 0 (0) 8 (2)
1 37 (88) 386 (94)
2 5 (12) 14 (3)
3 0 (0) 3 (1)
tent type
Acculink 1 (2) 40 (9.4)
Precise/Smart 45 (96) 301 (70)
NexStent 0 (0) 66 (16)
Mednova Xact 1 (2) 11 (3)
Wallstent 0 (0) 7 (2)
Wallgraft 0 (0) 1 (0.2)
ontinuous variables shown as means with SD in parentheses. Categorical variables
hown as frequencies with percentages in parentheses.
ACT  activated clotting time; CB  cutting balloon; PTA  percutaneous
ngioplasty.
Table 3. Lesion Characteristics of Slow Flow a
Lesion Variable
Number of lesions treated
1
2
3
Site of lesions treated
Left CCA
Left ICA
Left ICA/CCA
Right CCA
Right ICA
Right ICA/CCA
Lesion eccentricity
Heavy calcification
Lesion ulceration
Lesion length (mm)
Pre-procedural % stenosis
Pre-dilation balloon diameter (mm)
Pre-dilation balloon length (mm)
Stent diameter (mm)
Stent length (mm)
Post-stent dilation balloon diameter (mm)
Post-stent dilation balloon length (mm)
Continuous variables shown as means with SD in parenthes
parentheses.
CCA  common carotid artery; ICA  internal carotid arteryow and normal flow groups is shown in Table 3. A total of
4 lesions were treated during the 42 procedures in the
low-flow group. A total of 420 lesions were treated during
he 411 procedures in the normal flow group. Plaque
lceration (45% vs. 28%, p  0.021), larger stent diameter
7.9  0.7 mm vs. 7.4  1.4 mm, p  0.012), and smaller
ost-stent balloon dilation diameter (5.5  1 mm vs. 5.8
0.5 mm, p  0.026) were more commonly associated
ith slow-flow.
Using binary logistic regression, statistically significant
i.e., p  0.05) clinical, procedural, and lesion-related
nivariate predictors of slow-flow were determined and
ncluded: increased age, history of TIA/stroke within six
onths, history of congestive heart failure, lesion percent
tenosis at baseline, lesion ulceration, stent diameter, and
ost-stent balloon dilation diameter. A formal interaction
nalysis confirmed the absence of a significant interaction
etween these variables. The univariate predictors were
ntered into a multivariate logistic regression analysis. In-
reased patient age, a history of TIA/stroke within six
onths, and larger stent diameter were independently
redictive of the slow-flow phenomenon (Table 4). The C
tatistic for the model was 0.89.
linical outcomes. The 30-day incidence of stroke, death,
nd myocardial infarction among patients with slow-flow
as 9.5% (n  4), 0%, and 2.3% (n  1), respectively (Fig.
). All four strokes in this group occurred on the day of the
rocedure. Neurological symptoms were first noted after
etrieval of the filter in all four cases. Of the four strokes,
wo were classified as minor, with a normal neurological
xam at 30-day follow-up (National Institutes of Health
ormal Flow Groups
-Flow
 44)
Normal Flow
(n  420) p Value
(95) 409 (99)
(5) 4 (1)
(0) 1 (0.2)
(2) 18 (4)
(45) 179 (43)
(2) 17 (4)
(2) 15 (4)
(38) 174 (42)
(11) 16 (4)
(63) 232 (56)
(27) 123 (29)
(45) 118 (28) 0.021
 8.5 20  8.6
 7 86  8
 0.4 4.0  1
 5.1 22.1  4.9
 0.7 7.4  1.4 0.012
 7.5 28.6  6.8
 1 5.8  0.5 0.026
 6 22.3  5
tegorical variables shown as frequencies with percentages innd N
Slow
(n
40
2
0
1
20
1
1
16
5
28
12
20
20.2
88
3.9
22.7
7.9
29.3
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Slow-Flow During Carotid Artery Intervention October 18, 2005:1466–72troke Scale 0). Among patients with normal flow during
arotid intervention, the 30-day incidence of stroke, death,
nd myocardial infarction was 1.7% (n  7), 1.5% (n  6),
nd 1.2% (n  6) (Fig. 4). The pre-defined primary clinical
utcome of stroke and/or death at 30 days occurred in 9.5%
n  4) of patients with slow-flow and 2.9% (n  9) of
atients with normal flow (chi-square  4.73, p  0.03)
Fig. 4).
ISCUSSION
his is the first report that defines the predictors and
rognostic significance of patients experiencing slow-flow
uring carotid artery intervention using filter-type EPDs. In
his large single-center experience (n  414), slow-flow
ccurred in 10.1% of patients, and 9.3% of all carotid
rocedures. Significant multivariate predictors of the event
ncluded a recent history of TIA/stroke, increased patient
ge, and increased stent diameter. Slow-flow was associated
ith an adverse clinical outcome, with a 30-day incidence of
troke and/or death of 9.5%, compared to 2.9% among
atients with normal flow (p  0.03).
Despite the high frequency of slow-flow in this series, the
henomenon has not been well described in the carotid
ntervention literature. In a recent multicenter registry of
53 patients, slow-flow was noted in 7.9% of patients in
hom an EPD was utilized (2). Smaller single-center
tudies reported an incidence of between 7.2% and 22%
1,4). Together with the current study, these data support
hat the phenomenon is real and that, using the current
eneration of filter-type EPDs, the true incidence is likely to
e at least in the 8% to 10% range.
Previous studies have provided little further descriptive
etail about the phenomenon of slow-flow. In this series,
low-flow occurred exclusively in patients who had a stent
able 4. Multivariate Predictors of Slow-Flow
Variable p Value OR (95% CI)
ymptomatic carotid lesion 0.004 2.8 (1.4–5.6)
tent diameter 0.034 1.4 (1.02–1.9)
ge (per yr) 0.025 1.05 (1.01–1.09)
I  confidence interval; OR  odds ratio.t
igure 3. Thirty-day incidence of stroke, death, and myocardial infarction
MI) in patients with slow-flow and normal flow.laced, although it should be accepted that only eight
atients were treated with angioplasty alone. The event
ccurred predominantly after post-stent balloon dilatation,
lthough over a quarter occurred after deployment of the
tent alone. No-flow represents the most severe manifesta-
ion of the phenomenon, where antegrade flow completely
eases and occurred in nearly a quarter of the patients. The
emaining patients exhibited reduced antegrade flow, which
ncompasses a broad spectrum of flow impairment. In its
ildest form, the ICA fills completely but marginally slower
han the external carotid artery. In its most severe form, the
ontrast fills only part of the ICA lumen and moves very
lowly beyond the filter.
The underlying pathogenesis of slow-flow during carotid
ntervention with EPD is uncertain. One indisputable fact is
he observation that normal antegrade flow is restored in all
atients with slow-flow after retrieval of the filter EPD.
his clearly isolates the filter as the culprit and strongly
uggests that occlusion of the pores in the filter membrane
s responsible for the impairment in antegrade flow. Thus,
he filter-type EPD is converted into a partial or completely
cclusive device. The lack of antegrade flow would then
llow stagnation of the blood column proximal to the filter
nd the accumulation of microemboli and debris in this
olumn. Histopathological analysis of the debris released
uring carotid artery stenting and of the debris retrieved
rom the membranes of filter-type EPDs reveals the pres-
nce of amorphous material derived from the core of
therosclerotic plaque, principally lipid-laden macrophages,
holesterol clefts, and fibrin material (1,4–6). A rationale
ypothesis is that the phenomenon of slow-flow during
arotid intervention with EPD occurs due to an increased
xtrusion of these plaque elements during carotid interven-
ion. This is supported by the close temporal relationship of
low-flow to stent deployment and post-stent balloon dila-
ation, which are primarily responsible for procedure-related
laque embolization (7). Our finding that symptomatic
arotid lesions and increased stent diameter are independent
redictors of the phenomenon is also consistent with this
ypothesis. Symptomatic plaques are more likely to contain
igure 4. Kaplan-Meier estimate of survival free of stroke or death among
atients with slow-flow or normal flow during carotid intervention.he pathological elements that contribute to the particulate
d
v
m
m
u
a
p
f
a
a
h
s
s
d
w
t
d
d
e
r
p
c
r
a
a
t
e
r
d
l
c
t
l
d
c
(
a
t
p
F
d
s
f
F
c
N
1471JACC Vol. 46, No. 8, 2005 Casserly et al.
October 18, 2005:1466–72 Slow-Flow During Carotid Artery Interventionebris retrieved from filter-type EPDs after carotid inter-
ention (1,8). It also seems reasonable that plaque extrusion
ay be increased with larger stent diameter sizes. Slow-flow
ay actually serve as an important marker of vulnerable
nstable plaque that is prone to embolization, even among
symptomatic patients.
An alternative potential explanation for complete or
artial occlusion of the filter during slow-flow is the in-situ
ormation of thrombus in the filter device. Our data argues
gainst this explanation. Various measures of the degree of
nticoagulation in both groups (peak procedural ACT,
eparin dose/kg) were no different between patients with
low-flow and normal flow. All patients received the same
tandardized pre-procedural regimen of aspirin and clopi-
ogrel. Finally, total fluoroscopy times for the procedure
ere no different between the groups, making it unlikely
hat slow-flow occurred in patients with prolonged proce-
ures and waning levels of anticoagulation.
The importance of slow-flow is clearly underscored by the
isparity in clinical outcome between patients who experi-
nce the phenomenon and those who do not. Procedure-
elated stroke represents the major hazard observed in
atients with slow-flow, occurring in 9.5% of patients,
ompared to 1.7% of patients with normal flow. Magnetic
esonance imaging from one of the patients with slow-flow
nd stroke in this study is shown in Figure 5. The appear-
nce is that of multifocal punctate infarcts in the distribu-
ion of the anterior circulation, which is consistent with an
mbolic mechanism. It is unclear whether these emboli
igure 5. Magnetic resonance image from brain of patient with slow-flow
uring carotid intervention and post-procedural stroke. Image demon-
trates numerous punctate foci of restricted diffusion involving the right
rontal and parietal cortex (indicated by arrows).epresent a primary failure of the filter to capture extruded
t
sebris, or reflect the embolization of debris that accumu-
ated in the column of blood proximal to the filter under the
onditions of slow-flow and remained despite the aspiration
echniques we employed in this cohort. We suspect that the
atter is the more likely explanation, because the patients
eveloped neurological symptoms only after the filter was
ollapsed. In the first patient in which one of the authors
J.Y.) observed this phenomenon at another institution,
spiration was not performed before capturing the filter, and
he patient suffered a large stroke. This resulted in our
ractice of aspirating proximal to the filter after the recog-
igure 6. Histopathological appearance of debris aspirated from the
olumn of blood proximal to the filter during an episode of slow-flow. (A)
umerous amorphous lipoid masses (open arrow) and chronic inflamma-ory cells (arrow). (B) Cholesterol crystal (arrow). (C) Multiple spindle-
haped cells consistent with the appearance of smooth muscle cells.
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Slow-Flow During Carotid Artery Intervention October 18, 2005:1466–72ition of slow-flow in an attempt to remove this debris and
revent its distal embolization after retrieval of the filter.
he practice is supported by occasional histological analysis
f the aspirate obtained during cases of slow-flow that
emonstrate the presence of acellular and amorphous debris
ontaining lipid-rich macrophages and cholesterol crystals
Fig. 6). We strongly advise that this technique be employed
n all patients with angiographic evidence of slow-flow.
lthough we accept that strokes still occurred with in-
reased frequency in patients with slow-flow in this study,
ithout aspiration, it is our belief that the stroke rate would
ave been even higher, and that more of the slow-flow
atients would have suffered major strokes.
tudy limitations. The patient cohort in this observational
tudy represents a “high-risk” group with multiple comor-
idities, studied at a single institution, who were largely
reated using the Angioguard EPD and Precise nitinol
tent. Further examination of frequency, predictors, and
utcomes of slow-flow should be performed in “high-risk”
roups at other centers, in “lower-risk” cohorts, and using
ther types of EPDs and stents in order to confirm our
ndings. It is important to emphasize that the clinical
utcome of patients in this study with slow-flow during
arotid intervention reflects the outcome achieved using a
trategy of aspiration before filter retrieval. It is accepted
hat this strategy is not supported by rigorous clinical
nvestigation (i.e., randomized study), but seems entirely
easonable based on our current understanding of the
8henomenon of slow-flow. It is possible that the difference
n outcome between patients with and without slow-flow
ould be even greater if this strategy was not employed.
eprint requests and correspondence: Dr. Jay S. Yadav, Depart-
ent of Cardiovascular Medicine, The Cleveland Clinic Founda-
ion, 9500 Euclid Avenue, Desk F25, Cleveland, Ohio, 44195.
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